Labquality EQAS
NGS in clinical oncology
CLINICAL ONCOLOGY
Scheme information
Scheme
NGS in clinical oncology
Service by
Labquality
Target
Laboratories
Group
Clinical oncology
Sub-group
Oncology
Products
6811 /
NGS in clinical oncology, Breast cancer
Samples: 1 DNA sample as a FFPE scroll
Examinations: Genes PIK3CA, AKT1, PTEN
Rounds:
MAY
Accrediation: Not accredited
Results/sample set: 1
Additional information: Results should be reported according to the given genes and according to the laboratory's panel selection. The variants for the same genes vary across the different EQA products.
6812 /
NGS in clinical oncology, Colonrectal cancer
Samples: 1 DNA sample as a FFPE scroll
Examinations: Genes BRAF, KRAS, NRAS, PIK3CA, TP53
Rounds:
JUN
Accrediation: Not accredited
Results/sample set: 1
Additional information: Results should be reported according to the given genes and according to the laboratory's panel selection. The variants for the same genes vary across the different EQA products.
6813 /
NGS in clinical oncology, Lung cancer
Samples: 1 DNA sample as a FFPE scroll
Examinations: EGFR, KRAS, BRAF, MET, exon 14
Rounds:
JUN
Accrediation: Not accredited
Results/sample set: 1
Additional information: Results should be reported according to the given genes and according to the laboratory's panel selection. The variants for the same genes vary across the different EQA products.
6810 /
NGS in clinical oncology, Pan cancer
Samples: 1 DNA sample as a FFPE scroll
Examinations: Genes ALK, BRCA1, EGFR, ERBB2, RET, TP53. 6 genes including 9 variants.
Rounds:
APR
Accrediation: Not accredited
Results/sample set: 1
Additional information: Results should be reported according to the given genes and according to the laboratory's panel selection. The variants for the same genes vary across the different EQA products.